Jan Petracek is invited to speak at the DIA/MEB Excellence in Pharmacovigilance this week! Did you know that DIA organizes this training course in collaboration with the Dutch Medicines Evaluation Board (MEB)? This face-to-face course is designed to provide a strong foundation in all key aspects of European Post-Marketing Safety regulatory requirements.
Jan will share his gained knowledge about Risk Management Plans, the Effectiveness of Risk Minimisation Measures, and Risk Communication in the EU. In addition to that, he will be speaking about Signal Management in the EU.
If you are interested to learn more, the registration is still open! More information is available here: https://www.diaglobal.org/en/course-listing/training/2022/11/dia-meb-excellence-in-pharmacovigilance#showcontent